ES

Astrazeneca Plc Ordinary Shares(AZN)

Description

una empresa farmacéutica que desarrolla medicamentos innovadores y preparados farmacéuticos

Key stats

Earnings

  1. IMFINZI APPROVED IN US FOR EARLY BLADDER CANCER
  2. US FDA DECISION DATE ON CAMIZESTRANT EXTENDED
  3. DATROWAY APPROVED IN US FOR 1L TRIPLE-NEGATIVE BC
  4. ENHERTU RECOMMENDED IN EU FOR HER2+ SOLID TUMOURS